PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios

China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

Equity · Currency in HKD · Last updated Sep 28, 2023
SummaryFinancials

Company Info

ISINBMG210A71016
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$15.01B
EPSHK$0.58
PE Ratio6.13
Revenue (TTM)HK$10.34B
Gross Profit (TTM)HK$5.25B
EBITDA (TTM)HK$3.20B
Year RangeHK$3.18 - HK$5.24
Target PriceHK$7.60

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM2022202120202019
Revenue

Total Revenue

10.34B9.56B8.60B6.35B6.59B

Cost Of Revenue

3.78B3.61B3.35B2.32B2.55B

Gross Profit

6.56B5.95B5.25B4.04B4.04B
Operating Expenses

Selling General & Admin Expenses

3.78B3.37B3.31B685.24M612.98M

R&D Expenses

0.000.000.000.000.00

Total Operating Expenses

0.006.88B6.66B4.48B5.20B
Income

Income Before Tax

2.93B2.52B2.79B2.07B1.36B

Operating Income

3.12B2.70B2.76B1.87B1.39B

EBIT

0.000.002.18B1.87B1.39B

Earnings From Continuing Operations

0.002.10B2.41B1.78B1.13B

Net Income

2.40B2.08B2.40B1.79B1.15B

Income Tax Expense

0.000.00380.80M292.37M230.49M

Interest Expense

567.32M13.75M92.96M115.42M146.50M

Other Non Operating Income (Expenses)

0.000.000.000.000.00

Extraordinary Items

0.000.000.000.000.00

Discontinued Operations

0.000.000.000.000.00

Effect Of Accounting Charges

0.000.000.000.000.00

Non Recurring

0.000.000.000.000.00

Minority Interest

0.00-18.83M-2.47M104.71M135.74M

Other Items

0.000.000.000.000.00
Values in HKD except per share items